Ironsides Asset Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,491
Closed -$715K 97
2017
Q3
$715K Sell
3,491
-100
-3% -$23.3K 0.29% 46
2017
Q2
$873K Buy
3,591
+2,510
+232% +$590K 0.38% 38
2017
Q1
$258K Sell
1,081
-944
-47% -$220K 0.11% 71
2016
Q4
$425K Sell
2,025
-6,225
-75% -$1.29M 0.12% 111
2016
Q3
$1.9M Buy
8,250
+4,381
+113% +$1.07M 0.51% 44
2016
Q2
$894K Buy
3,869
+266
+7% +$61.3K 0.27% 66
2016
Q1
$966K Buy
3,603
+45
+1% +$12.9K 0.24% 81
2015
Q4
$1.11M Buy
+3,558
New +$1.06M 0.3% 67

Other funds holding AGN

Ironsides Asset Advisors's AGN Position: Q4 2017 in Review

Ironsides Asset Advisors sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 3,491 shares — an estimated $715K sold.

Ironsides Asset Advisors first reported a position in AGN in Q4 2015 and held it in 8 quarters. The position peaked at $1.9M in Q3 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Ironsides Asset Advisors reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Ironsides Asset Advisors sold 3,491 Allergan plc shares in Q4 2017, an estimated $715K.
  • Ironsides Asset Advisors first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
  • Ironsides Asset Advisors's Allergan plc position peaked at $1.9M in Q3 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Ironsides Asset Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.